191 related articles for article (PubMed ID: 15686919)
1. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
[TBL] [Abstract][Full Text] [Related]
2. FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A peripheral efficacious kappa opioid agonist with unprecedented selectivity.
Vanderah TW; Schteingart CD; Trojnar J; Junien JL; Lai J; Riviere PJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):326-33. PubMed ID: 14993260
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
[TBL] [Abstract][Full Text] [Related]
4. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
5. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
[TBL] [Abstract][Full Text] [Related]
6. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
7. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: I. In vitro pharmacological characterization and pharmacokinetic properties.
Valenzano KJ; Miller W; Chen Z; Shan S; Crumley G; Victory SF; Davies E; Huang JC; Allie N; Nolan SJ; Rotshteyn Y; Kyle DJ; Broglé K
J Pharmacol Exp Ther; 2004 Aug; 310(2):783-92. PubMed ID: 15054115
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and analgesic activity of analogs of U-50488, an opiate kappa-agonist].
Ma SC; Yang YL; Yuan XM
Yao Xue Xue Bao; 1991; 26(12):902-5. PubMed ID: 1668563
[TBL] [Abstract][Full Text] [Related]
9. The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.
Gottschlich R; Barber A; Bartoszyk GD; Seyfried CA
Drugs Exp Clin Res; 1995; 21(5):171-4. PubMed ID: 8846746
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.
Spetea M; Schüllner F; Moisa RC; Berzetei-Gurske IP; Schraml B; Dörfler C; Aceto MD; Harris LS; Coop A; Schmidhammer H
J Med Chem; 2004 Jun; 47(12):3242-7. PubMed ID: 15163203
[TBL] [Abstract][Full Text] [Related]
11. Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
Vanderah TW; Largent-Milnes T; Lai J; Porreca F; Houghten RA; Menzaghi F; Wisniewski K; Stalewski J; Sueiras-Diaz J; Galyean R; Schteingart C; Junien JL; Trojnar J; Rivière PJ
Eur J Pharmacol; 2008 Mar; 583(1):62-72. PubMed ID: 18282565
[TBL] [Abstract][Full Text] [Related]
12. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
13. Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats.
Shannon HE; Eberle EL; Mitch CH; McKinzie DL; Statnick MA
Neuropharmacology; 2007 Dec; 53(8):930-41. PubMed ID: 17959202
[TBL] [Abstract][Full Text] [Related]
14. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
15. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
[TBL] [Abstract][Full Text] [Related]
16. The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain.
Tsukahara-Ohsumi Y; Tsuji F; Niwa M; Hata T; Narita M; Suzuki T; Sasano M; Aono H
Eur J Pharmacol; 2011 Dec; 671(1-3):53-60. PubMed ID: 21970808
[TBL] [Abstract][Full Text] [Related]
17. Discovery, stereospecific characterization and peripheral modification of 1-(pyrrolidin-1-ylmethyl)-2-[(6-chloro-3-oxo-indan)-formyl]-1,2,3,4-tetrahydroisoquinolines as novel selective κ opioid receptor agonists.
Gan ZJ; Wang YH; Xu YG; Guo T; Wang J; Song Q; Xu XJ; Hu SY; Wang YJ; Wang DC; Sun DZ; Zhang D; Xi T; Li HD; Zhang HB; Hang TJ; Lu HG; Liu JG
Org Biomol Chem; 2015 May; 13(20):5656-73. PubMed ID: 25895552
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of pyrrolomorphinan derivatives as kappa opioid agonists.
Fujii H; Ida Y; Hanamura S; Osa Y; Nemoto T; Nakajima M; Hasebe K; Nakao K; Mochizuki H; Nagase H
Bioorg Med Chem Lett; 2010 Sep; 20(17):5035-8. PubMed ID: 20685120
[TBL] [Abstract][Full Text] [Related]
19. kappa-Opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753.
Gottschlich R; Krug M; Barber A; Devant RM
Chirality; 1994; 6(8):685-9. PubMed ID: 7857777
[TBL] [Abstract][Full Text] [Related]
20. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
